Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Bone Neoplasms × Cefazolin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 Wound Infection 2 Infections 2 Surgical Wound Infection 1 Laryngeal Neoplasms 1 Bone Neoplasms 1

Interventions

Ibandronic Acid 5 Zoledronic Acid 3 Denosumab 3 pembrolizumab 2 Sunitinib 2 Radiotherapy, Intensity-Modulated 2 Nivolumab 2 Methods 2 Interviews as Topic 2 Injections 2 Curettage 2 selinexor 1 saracatinib 1 ridaforolimus 1 radium Ra 223 dichloride 1 pegfilgrastim 1 olaparib 1 montanide ISA 51 1 lentiviral minigene vaccine of COVID-19 coronavirus 1 endostar protein 1 cc-486 1 angiotensin I (1-7) 1 Vincristine 1 Transplantation, Homologous 1 Transplantation, Autologous 1 Transcranial Direct Current Stimulation 1 Trabectedin 1 Tomography, Spiral Computed 1 TES 1 Surveys and Questionnaires 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01479283 2021-03-11

PARITY

McMaster University

Phase 3 Completed

Bone Neoplasms, Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡